These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 31755336)

  • 21. 3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation.
    Sobhy MK; Mowafy S; Lasheen DS; Farag NA; Abouzid KAM
    Bioorg Chem; 2019 Aug; 89():102988. PubMed ID: 31146197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Novel EGFR Inhibitors for the Targeted Therapy of Colorectal Cancer Using Pharmacophore Modelling, Docking, Molecular Dynamic Simulation and Biological Activity Prediction.
    Krishnan K A; Valavi SG; Joy A
    Anticancer Agents Med Chem; 2024; 24(4):263-279. PubMed ID: 38173208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacophore-Based Virtual Screening and In-Silico Explorations of Biomolecules (Curcumin Derivatives) of
    Ejaz SA; Aziz M; Fawzy Ramadan M; Fayyaz A; Bilal MS
    Molecules; 2023 May; 28(10):. PubMed ID: 37241785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of novel PI3Kδ inhibitors by docking, ADMET prediction and molecular dynamics simulations.
    Liu YY; Feng XY; Jia WQ; Jing Z; Xu WR; Cheng XC
    Comput Biol Chem; 2019 Feb; 78():190-204. PubMed ID: 30557817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtual screening filters for the design of type II p38 MAP kinase inhibitors: a fragment based library generation approach.
    Badrinarayan P; Sastry GN
    J Mol Graph Model; 2012 Apr; 34():89-100. PubMed ID: 22306417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular dynamics simulation and free energy calculation studies of kinase inhibitors binding to active and inactive conformations of VEGFR-2.
    Wu X; Wan S; Wang G; Jin H; Li Z; Tian Y; Zhu Z; Zhang J
    J Mol Graph Model; 2015 Mar; 56():103-12. PubMed ID: 25594497
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A combination of 2D similarity search, pharmacophore, and molecular docking techniques for the identification of vascular endothelial growth factor receptor-2 inhibitors.
    Ai G; Tian C; Deng D; Fida G; Chen H; Ma Y; Ding L; Gu Y
    Anticancer Drugs; 2015 Apr; 26(4):399-409. PubMed ID: 25569705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exploring binding mechanisms of VEGFR2 with three drugs lenvatinib, sorafenib, and sunitinib by molecular dynamics simulation and free energy calculation.
    Wang Y; Peng C; Wang G; Xu Z; Luo Y; Wang J; Zhu W
    Chem Biol Drug Des; 2019 May; 93(5):934-948. PubMed ID: 30689282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and characterization of agnuside, a natural proangiogenic small molecule.
    Pillarisetti P; Myers KA
    Eur J Med Chem; 2018 Dec; 160():193-206. PubMed ID: 30340142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
    Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
    J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virtual screening and synthesis of new chemical scaffolds as VEGFR-2 kinase inhibitors.
    Elsayed MS; El-Araby ME; Serya RT; Abouzid KA
    Arzneimittelforschung; 2012 Dec; 62(12):554-60. PubMed ID: 23023518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CHK1 kinase inhibition: identification of allosteric hits using MD simulations, pharmacophore modeling, docking and MM-PBSA calculations.
    Al-Shar'i N; Musleh SS
    Mol Divers; 2022 Apr; 26(2):903-921. PubMed ID: 33686514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening.
    Li C; Zhang X; Zhang N; Zhou Y; Sun G; Zhao L; Zhong R
    Molecules; 2020 Jan; 25(1):. PubMed ID: 31935979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An integrated virtual screening approach for VEGFR-2 inhibitors.
    Zhang Y; Yang S; Jiao Y; Liu H; Yuan H; Lu S; Ran T; Yao S; Ke Z; Xu J; Xiong X; Chen Y; Lu T
    J Chem Inf Model; 2013 Dec; 53(12):3163-77. PubMed ID: 24266594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches.
    Nada H; Lee K; Gotina L; Pae AN; Elkamhawy A
    Comput Biol Med; 2022 Mar; 142():105217. PubMed ID: 35032738
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Virtual Screening Using Pharmacophore Models Retrieved from Molecular Dynamic Simulations.
    Polishchuk P; Kutlushina A; Bashirova D; Mokshyna O; Madzhidov T
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31757043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacophore-based virtual screening of ZINC database, molecular modeling and designing new derivatives as potential HDAC6 inhibitors.
    Poonia P; Sharma M; Jha P; Chopra M
    Mol Divers; 2023 Oct; 27(5):2053-2071. PubMed ID: 36214962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uncovering Molecular Bases Underlying Bone Morphogenetic Protein Receptor Inhibitor Selectivity.
    Alsamarah A; LaCuran AE; Oelschlaeger P; Hao J; Luo Y
    PLoS One; 2015; 10(7):e0132221. PubMed ID: 26133550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Computational insights into allosteric inhibition of focal adhesion kinase: A combined pharmacophore modeling and molecular dynamics approach.
    Kumar V; Singh P; Parate S; Singh R; Ro HS; Song KS; Lee KW; Park YM
    J Mol Graph Model; 2024 Jul; 130():108789. PubMed ID: 38718434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.